Phase III - Biobanking.com

Home Tags Phase III

BrainStorm Cell Therapeutics Passes Safety Milestone In Phase 3 Trial Of NurOwn® Therapy for...

News Stories David Orchard-Webb, PhD

BrainStorm Cell Therapeutics Inc., founded in 2004, based in New York City, is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company...

⭐ Recently Featured

Biobanking: A Silent Hero in the Fight Against Climate Change

Expert Contributions

Biobanking: A Silent Hero in the Fight Against Climate Change

Unlocking the Future Evolution and Impact of Biobanking Networks in the Next Decade

Unlocking the Future: Evolution and Impact of Biobanking Networks in the Next Decade

Expert Contributions

Unlocking the Potential of Multiomics in Biobanking: An Interview with Dr. Aarno Palotie, Scientific Director of FinnGen

Unlocking the Potential of Multiomics in Biobanking: An Interview with Dr. Aarno Palotie, Scientific Director at FinnGen

DNA/RNA Banking

Leverage a Biorepository Management System for Decarbonization in Biobanking

Driving Decarbonization in Biobanking for Environmental Sustainability with a Biorepository Management System

Data & Informatics

Automated Biobanking: Advantages, Benefits and Future Directions

Automated Biobanking: Advantages, Benefits and Future Directions

🔥 Popular Posts

Biobank Profiles

10 Largest Biobanks in the World

Biobanking LIMS Softwares

10 Top Laboratory Information Management Systems (LIMS Softwares) for Biobanking

Data & Informatics

Biobank Facilities

Biobank versus Biorepository: What’s in a Name?

Insights & Opinions

Biobanks can comply with regulatory requirements by following ISBER Best Practices.

Biobanking Science: ISBER Best Practices for Biobanks

Biopreservation Science

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

X